Reply to Thomas Gevaert, Markus Eckstein, Rodolfo Montironi, and Antonio Lopez-Beltran's Letter to the Editor re: Maud Rijnders, Astrid AM van der Veldt, Tahlita CM Zuiverloon, et al. PD-L1 Antibody Comparison in Urothelial Carcinoma. Eur Urol 2019;75:538-40

2019-06-01

Additional Metadata
Persistent URL	doi.org/10.1016/j.eururo.2019.01.039, hdl.handle.net/1765/116767
Journal	European Urology : Official Journal of the European Association of Urology
Organisation	Department of Medical Oncology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Rijnders, M., van der Veldt, A., de Wit, R., & Leenders, G. (2019). Reply to Thomas Gevaert, Markus Eckstein, Rodolfo Montironi, and Antonio Lopez-Beltran's Letter to the Editor re: Maud Rijnders, Astrid AM van der Veldt, Tahlita CM Zuiverloon, et al. PD-L1 Antibody Comparison in Urothelial Carcinoma. Eur Urol 2019;75:538-40. European Urology : Official Journal of the European Association of Urology, 75(6), E160–E161. doi:10.1016/j.eururo.2019.01.039

Publication